Pyogenic granuloma (PG) is a benign vascular proliferation that may affect the nails. Treatment is surgical, associated to or preceded by topical therapy. Based on previous studies showing that b-blockers increase the regression of PGs,4 we verified the effectiveness of topical 1% propranolol (1% cream in occlusion) cream on periungual and subungual PGs of hand and feet in 10 patients.

Piraccini, B., Alessandrini, A., Dika, E., Starace, M., Patrizi, A., Neri, I. (2016). Topical propranolol 1% cream for pyogenic granulomas of the nail: Open-label study in 10 patients. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 30(5), 901-902 [10.1111/jdv.13071].

Topical propranolol 1% cream for pyogenic granulomas of the nail: Open-label study in 10 patients

PIRACCINI, BIANCA MARIA;ALESSANDRINI, AURORA MARIA;DIKA, EMI;STARACE, MICHELA;PATRIZI, ANNALISA;NERI, IRIA
2016

Abstract

Pyogenic granuloma (PG) is a benign vascular proliferation that may affect the nails. Treatment is surgical, associated to or preceded by topical therapy. Based on previous studies showing that b-blockers increase the regression of PGs,4 we verified the effectiveness of topical 1% propranolol (1% cream in occlusion) cream on periungual and subungual PGs of hand and feet in 10 patients.
2016
Piraccini, B., Alessandrini, A., Dika, E., Starace, M., Patrizi, A., Neri, I. (2016). Topical propranolol 1% cream for pyogenic granulomas of the nail: Open-label study in 10 patients. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 30(5), 901-902 [10.1111/jdv.13071].
Piraccini, B.M.; Alessandrini, A.; Dika, E.; Starace, M.; Patrizi, A.; Neri, I.
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/519180
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 9
  • Scopus 31
  • ???jsp.display-item.citation.isi??? 25
social impact